Implantable device revolutionizes thyroid management

A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status, for conditions like hypo- and hyperthyroidism, in real time.

When Wegovy Doesn’t Work for Weight Loss

When former U.K. Prime Minister Boris Johnson’s announced last week that semaglutide (Ozempic/Wegovy) didn’t work for him, it served as a reminder that not all

June 28, 2023

Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch

What You Should Know: – Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will

April 4, 2024

The end of 23andMe’s drug discovery dream

23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, announced Monday that it would halt its

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.